APOC1 anticorps (HRP)

N° du produit ABIN7449300

Cet anticorps anti-APOC1 est un anticorps Chèvre Polyclonal détectant APOC1 dans WB et ELISA. Adapté pour Humain.

Aperçu rapide pour APOC1 anticorps (HRP) (ABIN7449300)

Antigène: APOC1 (Apolipoprotein C-I (APOC1))

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp APOC1 est conjugé à/à la HRP

Application: Western Blotting (WB), ELISA

Clone: H07

Détail du produit anti-APOC1 anticorps (HRP)

Fonction: Goat anti-Human Apo CI [H07] Antibody HRP Conjugated

Immunogène: Human Apolipoprotein CI

Isotype: IgG

Information d'application

Indications d'application:

WB: 1:1,000 - 1:4,000

ELISA: 1:1,000 - 1:4,000

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: 50 mM PBS, 0.1 M NaCl, and 0.01 % Thiomersal, pH 7.4

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Date de péremption: 12 months

Détails sur APOC1

Antigène: APOC1 (Apolipoprotein C-I (APOC1))

Autre désignation: ApoCI

Sujet: Background: ApoCI contains 57 amino acid residues and the m.w. is 6.6 kDa (Jackson et al., 1974). ApoCI has been found to activate LCAT (Liu and Subbaiah 1993). Apo CI is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. Apo CI is also an inhibitor of the plasma cholesteryl ester transfer protein and of fatty acid uptake into tissues (Shachter, 2001). This inhibition role can potentially regulate several lipase enzymes. (Poensgen, 1990, Conde-Knape et al., 2002, Berbee et al., 2005)

ID gène: 341

NCBI Accession: NP_001636

UniProt: P02654

Pathways: Apoptose